420 with CNW – Cannabis Inhalers Could Be the Next Asthma and Cancer Pain Medication

Whole smoking is the most common administration method for medical cannabis, not all patients are willing or able to use this method. For example, those who have respiratory challenges like asthma are unable to smoke cannabis because it may aggravate their condition. Terminally ill patients may also find it hard to smoke marijuana as part of their treatment. For such patients, two Israeli companies have teamed up to develop cannabis inhalers through which they can take their medication.

The two firms are Panaxia Pharmaceuticals and Rafa Pharmaceuticals. The two companies are working together to bring marijuana inhalers to the market so that patients have one more way to get their medication.

For now, the companies are targeting asthma and the pain suffered by cancer patients. The companies hope to avail an administration mode that will bring quick relief to cancer pain or respiratory distress resulting from asthma symptoms.

This administration mode may easily gain acceptance in the market for several reasons.

First, inhalers aren’t a new mode of administering medication to patients. Asthma sufferers carry them around, so it would not be hard for them to switch to the cannabis version.

Secondly, it is possible to determine what precise dose of cannabis a patient should receive when using inhalers since the patient can be told to inhale a given number of times at stipulated intervals in order to get the right dose of cannabis into the body. Medical practitioners can therefore easily see cannabis as medicine if its dosage can be controlled.

Additionally, inhalation can provide faster therapeutic outcomes when compared to other modes, such as consuming cannabis edibles. This is precisely why asthma sufferers often carry an inhaler so that they can use it and see results faster when an asthma attack occurs.

At the moment, the innovators are conducting clinical trials together with the Israeli Ministry of Health in order to ascertain whether the product is ready to hit the market, or some kinks remain which need to be resolved.

Meanwhile, the companies have decided to start a marketing drive for the inhalers while the clinical trial is ongoing.

The plan is to avail the inhalers on the Israel market later this year. Only patients with a doctor’s prescription will be able to access the product. It is not yet clear when the two companies will start exporting their invention to the rest of the world. Remember, the Israeli parliament passed a law towards the end of last year allowing companies that have been licensed by the state to export medical marijuana.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulate the two Israeli companies for finding a solution to administering medical cannabis to patients who are unable to use the modes that are currently available on the market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Demand for Medical Cannabis Skyrockets on Rhode Island

As legislators on Rhode Island are thinking about legalizing recreational cannabis, the data on medical cannabis sales shows that the volume of products sold is setting state records year by year.

Currently, the state has three licensed dispensaries selling medical cannabis products. These dispensaries are on course to sell medical cannabis products worth about $56 million during the 2019 fiscal year.

If that target is hit, it will mark a 46.6 percent increase from the total sales of the previous fiscal year (2018). Medical cannabis sales for 2018 were also approximately 33.3 percent higher than what was registered in 2017.

As you can see, the medical cannabis industry on Rhode Island seems to be growing at an unstoppable pace year by year.

Rhode Island has a fairly short list of medical cannabis qualifying conditions when compared to other states where similar programs exist. However, the definition of those conditions is broad and it allows anyone with the symptoms of the listed conditions to access medical cannabis.

The state has about 18, 200 patients who are active on the medical marijuana program. Active patients are those who regularly buy medical cannabis products from the licensed dispensaries.

The uptick in medical cannabis sales has given the state a much-needed boost to its revenue. For example, the state earned $2.75 million as taxes on various aspects of the medical cannabis industry.

In this fiscal year, the state expects to earn almost double what it earned during the last fiscal year. Projections indicate that the state will collect about $5.4 million in taxes from the medical cannabis industry.

In the meantime, there are proposals to legalize recreational cannabis and also expand the medical cannabis sector. One of the proposals seeks to increase the number of dispensaries to nine.

Previous attempts to increase the number of dispensaries have been successfully resisted by the existing three dispensaries who argued that bringing in more players would hurt their businesses and result in possible closures.

However, those who want more dispensaries to be licensed argue that patients aren’t having sufficient access to dispensaries since the existing ones aren’t equally spread out across the state. Additionally, the lack of robust competition in the medical cannabis sector has denied patients competitive prices and access to a broader variety of products.

Advocates are therefore asking regulators to give priority to dispensaries that wish to operate in areas where none currently exists, and new operators should be brought on board before the existing ones are allowed to open additional compassion centers (medical cannabis dispensaries).

These reforms seem reasonable enough, and the regulators would be well advised to act upon the suggestions made. Cannabis Strategic Ventures, Inc. (OTC: NUGS) and Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) hope that the state will act on the proposed reforms so that patients can have easier access a wider variety of products at competitive prices.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Research Suggests You Could Be Storing Cannabis Improperly

Ask anyone how they store their cannabis and you are likely to hear that they place it in an airtight plastic container stored away from direct sunlight. While this has been the norm for cannabis storage, new research suggests that such a method may not preserve the ingredients of your valuable stash for long.

The Italian study compared how THC content was preserved if cannabis was stored in four different ways for 100 days.

First, the researchers looked at what would happen to cannabis if it were stored for 100 days in a bright room at room temperature. This method of storage resulted in a 13 percent drop in the THC content of the cannabis.

The researchers also looked into what would happen to the THC content of cannabis that has been stored in a dark room at room temperature. The cannabis lost 11 percent of its THC content.

How do most processors store their cannabis? You guessed right, in a dark room at room temperature. These manufacturers may be slapping themselves in the face as they read this!

Next, the researchers looked at what would happen if a batch of cannabis was stored inside a refrigerator whose temperature was maintained at 4°C. There was a substantial reduction in the drop of THC using this method of storage.

The researchers then upped the ante and kept some marijuana in a freezer for 100 days. The temperature inside the freezer was maintained at -20°C. Tests revealed that there was no noticeable change in the THC content if the cannabis was stored in the freezer.

The researchers concluded that the best way to store cannabis in order to preserve its constituents was by freezing it. Storage in an airtight container in a dark room only works for short-term storage, they added.

The researchers also revealed that the CBD content of cannabis barely changes over time regardless of how you choose to store the marijuana. People who have no interest in THC shouldn’t therefore fret about how they keep their cannabis products.

However, the findings of this study should not be generalized as applicable to all the attributes or components of cannabis. For example, the study didn’t look into how the flavor or scent of cannabis was affected by the four storage methods investigated.

As you wait for research to be done on that, you can conduct your own little experiments to see how your perception of those attributes is affected when you store marijuana in different ways.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome the insights that the study has shed on the different storage options for cannabis products.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – THC may be More Therapeutic than CBD, Study Finds

From the reports in the media and what people discuss, one is led to believe that CBD (cannabidiol) contains all the medicinal benefits in the cannabis plant while THC (tetrahydrocannabinol) symptomizes everything that is bad about cannabis since it is psychoactive. However, the findings of a recent study may turn this popular belief on its head.

According to a study whose findings appeared in the Scientific Reports Journal, THC seems to have a higher link with the relief of disease symptoms when compared to CBD.

The researchers from the University of New Mexico studied the data provided by medical cannabis users in the U.S. regarding various aspects of the medical cannabis that they consumed. The ReLeaf app allows patients to indicate various things, such as what they are suffering from, what marijuana strains they are consuming, how they are consuming that marijuana and what effects they notice after consuming medical cannabis.

The researchers looked at the data and found that the patients who used marijuana strains that had higher levels of THC when compared to the CBD content reported superior symptom relief unlike those patients whose medical marijuana had low levels of THC and higher levels of CBD.

Sarah See Stith, one of the co-authors of the research commented that their study was important in light of the fact that not enough information is given to patients when they want to try medical cannabis for their conditions.

Stith pointed out that almost all patients get a recommendation from a doctor and are on their own in terms of selecting the products to use. Some of those patients rely on their prior experience when they used to consume recreational marijuana. Others talk to family and friends while some go to the internet to educate themselves about medical cannabis. The staff at medical cannabis dispensaries are often poorly trained, so they cannot be relied upon to give dependable advice on the appropriate medical cannabis products for patients.

Stith thinks that their research findings can help to initiate a discussion and further research into how cannabis works to treat or provide symptomatic relief.

This research is also important because it comes at a time when the U.S., the UN and other international bodies are on the verge of deciding whether to reschedule cannabis or leave it in the most restrictive categories of the national/international treaties controlling narcotic substances.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome this research and hope that those findings will be considered by those who formulate cannabis policies and regulations in Washington.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Federal Reserve Boss Asks Congress for Clarity on Cannabis Banking

Jerome Powell, the chairman of the Federal Reserve, has asked the federal government to provide clarification on matters of banking services for the cannabis industry. Powell made these comments while addressing the Finance Committee of the U.S. Senate.

He was referring to the difficulties that financial institutions face as they wish to serve cannabis businesses in states that have legalized the substance, but those same institutions feel hamstrung by federal banking laws that still regard marijuana as an illegal substance.

It is not just banks and credit unions that are in this difficult position. Even supervisors and regulators face the same dilemma because it isn’t clear where they should draw the line between what is permissible under state law and what aspects of the federal banking laws to implement or place on the backburner.

When asked a follow up question, Jerome Powell also revealed that the clarification provided should also put the record straight on issues of insurance for the marijuana industry.

As things stand, the cannabis industry is still unable to obtain insurance in the same way that other businesses can. This is a serious problem because it denies the cannabis industry the protections provided by insurance.

This isn’t the first time that the Federal Reserve boss is expressing these sentiments. He is on record to have stated the same concerns during a press conference last year. Powell is reported to have said that while his work has nothing to do with cannabis, the institution he leads is concerned about the nascent industry because of the possible impacts to the financial sector if things aren’t handled correctly.

Steven Mnuchin, the Treasury Secretary, has also expressed a desire to see the banking concerns of the cannabis industry addressed. He went as far as saying these issues top the list of the matters that his department is concerned about.

If the indicators coming from Congress are anything to go by, 2019 may well be the year when the concerns of Mnuchin and Powell (as well as the cannabis industry) get addressed. A subcommittee of the 116th Congress is already holding hearings at which different stakeholders, such as marijuana businesses, are providing their submissions on matters of cannabis banking.

These hearings arise out of a bi-partisan bill that seeks to make it possible for cannabis businesses to keep their money in banks without any fear that the federal government will act against them or victimize the banks that have accepted to do business with the cannabis companies.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) will be extremely relieved if the calls by the Federal Reserve boss and the Treasury Secretary result in concrete steps to ease banking for the cannabis industry in the U.S.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Judge Faults Walmart in Arizona Medical Cannabis Case

A federal judge in Arizona has faulted Walmart for dismissing an employee who tested positive for cannabis even after that employee informed her employer that she had a valid medical marijuana card issued by the state.

It all started when Carol Whitmire sustained an injury while doing her work in one of Walmart’s stores in May 2016. Whitmire, who had worked with the same company for eight years, was immediately rushed to receive medical care after the accident. Blood and urine samples were also taken for analysis as part of Walmart’s policy.

Whitmire informed the HR department about her status as a medical cardholder after that incident and she continued to work after she recovered. However, she was terminated in July for being in contravention of Walmart’s policy on drugs.

Consequently, Whitmire sued Walmart for discrimination and wrongful dismissal. Walmart responded by telling court that it had a right to dismiss Whitmire due to her positive drugs test results.

However, court disagreed and pointed out that Walmart failed to prove that the positive drugs test indicated that Carol Whitmire had been working while intoxicated with marijuana. Had Walmart provided such proof, the court may have considered their assertion that they had good faith in terminating Whitmire.

Whitmire’s attorney, Joshua Carden, applauded the decision of Judge James Teilborg. Carden said that the judge had set a precedent that paved the way for private right-of-action lawsuits under the Arizona medical marijuana laws.

Joshua Carden revealed that the court would soon set a date for delivering its ruling regarding the possibility of reinstating Whitmire, as well as determining how much is due to her for damages and costs for the suits she filed.

Walmart was also glad that the federal court dismissed some of the claims made by Carol Whitmire in her suit. The company reiterated its ceaseless efforts to provide a safe environment for all its customers and associates.

Cases like Carol Whitmire’s are likely to crop up frequently because there is a lot that is still not known about cannabis. For example, for how long can someone remain impaired after consuming cannabis? Part of the reasons why Walmart couldn’t be justified to fire Whitmire is that it wasn’t clear whether a positive drugs test meant that Whitmire was under the influence while at work. Until scientific studies resolve this grey area, employers and employees will not be certain where the boundary is.

All in all, Cannabis Strategic Ventures, Inc. (OTC: NUGS) as well as Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) welcome the judgment that made it clear that patients using medical marijuana legally will not lose their jobs just because they test positive for cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Cultivators Profit from Growing Legal Market

CannabisNewsWire Editorial Coverage: The growth the legal cannabis market has created has turned cultivation facilities into invaluable assets.

  • The cannabis market is predicted to generate $146 billion in revenues by 2025.
  • Legal changes are accelerating this expansion in the United States and beyond.
  • Cultivation facilities are fundamental to this growth, providing the raw materials for the cannabis industry.

Cannabis Strategic Ventures (OTC: NUGS) (NUGS Profile) recently announced plans to establish a multi-acre cultivation facility in California to meet market demands. Tilray Inc. (NASDAQ: TLRY) is increasing its cultivation space through the acquisition of Natura Naturals Holdings. In addition, the need to equip cultivation facilities is fueling growth for hydroponic suppliers such as GrowGeneration Corp. (OTCQX: GRWG). Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has issued a letter of intent to acquire Whistler in an effort to increase…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Cannabis should be Reclassified Internationally, Says World Health Organization Committee

According to a leaked letter written by the World Health Organization’s Director General (Tedros Adhanom Ghebreyesus) to the UN Secretary-General, marijuana should be rescheduled from the most restrictive categories to less strict categories in all international treaties.

The recommendations in this letter were scheduled to be released publicly last year in December but this didn’t happen for unknown reasons.

According to the recommendations of the expert committee that studied the matter, whole-plant marijuana and marijuana resin should be removed from schedule IV (the most restrictive category) and left in schedule I.

The World health Organization also wants to be categorical and state that any cannabis products that contain less than 0.2 percent THC content aren’t subjected to any international controls. Previously, CBD didn’t appear anywhere in the international treaties that categorize different substances, so it was unclear what the position of the international body was on this substance. The letter now puts this matter to rest.

These recommendations will go to the UN Commission on Narcotic Drugs where 53 nations will cast a vote either to adopt the recommendations or reject them. Several countries, such as China and Russia, are expected to vote against the recommendations due to those countries’ history of being unwilling to see reforms in drugs laws.

However, other countries, such as Uruguay and Canada are certainly going to vote for reclassification, as will other European and South American countries where medical cannabis is legal.

It is harder to predict which way the U.S. vote will go. President Trump is quoted to have said that his administration respects the right of U.S. states to enact and implement their own marijuana laws, but the federal government has been reluctant to reform its own cannabis laws. One will therefore just have to wait and see how the U.S. representative at the UN votes when these recommendations are tabled.

While the recommendations contained in that WHO letter will not create any major legal shockwaves, they do have potentially serious political implications.

For starters, the rescheduling recommendations are a tacit admission that the UN and other world bodies made a grave error to classify marijuana as a substance that has no medicinal value. This decision seems to have been based on political considerations rather than being rooted in scientific data.

Secondly, the recommendations will embolden many countries to pass their own marijuana laws, as has been the case in the dozens of countries around the world that have legalized medical cannabis despite the current classification of marijuana as a substance with no known medical value.

Cannabis Strategic Ventures, Inc. (OTC: NUGS), Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and the cannabis industry in its entirety are waiting with bated breath to see how events will unfold worldwide once the recommendations of the UN are passed.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Florida Governor wants Smokable Marijuana Ban Ended

Gov. Ron DeSantis of Florida has spoken out against the medical marijuana law and threatened to step in decisively if the legislature doesn’t amend that law to permit patients to smoke medical cannabis.

The Republican Governor wants the state to have a new law that puts an end to the ban on smokable marijuana and also loosen the restrictions on the licensing conditions for treatment centers. DeSantis wants this law by mid-March.

The Governor feels that Florida voters spoke clearly enough when they approved medical marijuana, so the legislators should pass legislation that is in line with the wishes of the people. A reported 71 percent voted to legalize medical cannabis in 2016.

DeSantis says that he will drop the state’s appeals against the rulings made regarding the smokable cannabis ban as well as the legal challenge to the licensing requirements. This step will leave the courts to make a binding decision that will compel the regulators to change the existing provisions of the medical marijuana law.

However, the Governor doesn’t want to use the judicial system to effect change. Instead, he would prefer to see the necessary changes made by the legislative arm of the state, but he will have no other choice if the legislators don’t do as required within a few weeks after the new session opens on March 5.

The appeals DeSantis refers to were launched by the previous Governor (Rick Scott) after a circuit court decided that the ban on smoking medical cannabis was unconstitutional. Scott is now a Senator and DeSantis replaced him as Governor.

DeSantis spoke during a media address with John Morgan, a personal injury lawyer who sued the state over the ban on smoking medical cannabis. Morgan remarked that the no smoking issue wasn’t a joking matter and that it will be overturned one way or the other.

In response, the new Republican legislative leaders in the Senate and the House promised to work with the Governor in order to secure the necessary changes to the medical marijuana law.

It is good to see that the Governor is exerting his weight in order to help patients to have as many different ways to consume medical cannabis as is possible. Actually, the smokable cannabis may be the most affordable option for many of those patients, so keeping it off the table may impose a financial strain on people who are already struggling with serious medical conditions. The entire marijuana industry, including Cannabis Strategic Ventures, Inc. (OTC: NUGS) and Youngevity International, Inc. (NASDAQ: YGYI), supports the position taken by Governor DeSantis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Liquor Sales Unaffected by Marijuana Legalization, Study Finds

There were fears that the legalization of adult-use marijuana in different U.S. states would trigger a decline in alcohol sales as consumers switch to marijuana instead of taking alcohol. Numerous reasons, such as the hangovers associated with alcohol consumption, were cited as factors that would impact alcohol sales once cannabis was legalized. However, a recent study conducted by the Distilled Spirits Council has found that no such slump in sales has occurred in the three states where recreational cannabis has been legal for the longest time in the U.S.

The alcohol trade association reported that the trends in alcohol sales remained consistent regardless of marijuana legalization in Washington, Oregon and Colorado.

The Distilled Spirits Council analyzed the per-capita alcohol consumption data in the three states from two years before legalization occurred to four years after legalization.

The data showed that the sales of spirits increased by 3.6 percent in Oregon and 7.6 percent in Colorado.

However, wine did not fare the same way in all the three states. Washington registered a drop in sales during the time studied by the Council. At the same time, an upward trend was noticed in wine sales in Oregon and Colorado.

Beer sales have generally been declining for over a decade, and the analysts weren’t surprised to find that beer continued to lose its market share to spirits and wine even after marijuana became legal for adult-use in the three states.

Vivien Azer, one of the analysts who pored over the alcohol sales data commented that lower-end beers faced the greatest risk of losing their market share because they were largely consumed by lower-income Caucasian men who often faced a choice between buying cannabis and taking a beer. The data shows that cannabis is emerging as the winner when such a choice has to be made.

Wines and distilled spirits appeared to be insulated from such pressures because they tend to be consumed by higher-income earners who can afford to consume marijuana and their favorite alcoholic drink. Besides, cocktails are increasing in popularity among women, so that demographic alone can keep the sales of wines and spirits up.

All the same, many industry watchers are cautioning that it is still early days to conclude that marijuana will not eat into the market share of alcohol. Different generations and demographics are likely to respond differently when marijuana becomes an option for them. As recent polls show, marijuana is clearly becoming a favorite across the board. Industry players like Canopy Rivers Inc. (TSX.V: RIV) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) hope that such goodwill translates into the spending of disposable income on marijuana.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com